Profil
Dr. Pierre E.
Etienne, MD, is a Principal at Decision Options LLC.
In addition to his role with Decision Options, Dr. Etienne is Chief Development Officer of Targanta Therapeutics, Inc. and Targanta Therapeutics Corp.
He was a Senior Executive in Pfizer Worldwide Development Operations.
He is a Director of ESVEE Pharmaceuticals Private Limited in Pune, India, on the Advisory Board of Del-Mar Therapeutics, La Jolla, CA, and on the development council of Neurogen, Inc. in Branford, CT.
Dr. Etienne holds an MD from Univeristé de Liège, Belgium and trained in Neurochemistry and Psychiatry at McGill University in Montreal.
Anciens postes connus de Pierre E. G. Etienne
| Sociétés | Poste | Fin |
|---|---|---|
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Corporate Officer/Principal | 30/06/2010 |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | - |
Decision Options LLC
Decision Options LLC Investment ManagersFinance Decision Options provides Artificial Intelligence driven decision models for businesses of all sizes and industries. They get rewarded based on the actual value delivered and seek a long relationship with their clients resulting in measurable shareholder value enhancement. | Analyst-Equity | - |
| PFIZER INC. | Directeur des opérations | - |
Formation de Pierre E. G. Etienne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Targanta Therapeutics Corp.
Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Decision Options LLC
Decision Options LLC Investment ManagersFinance Decision Options provides Artificial Intelligence driven decision models for businesses of all sizes and industries. They get rewarded based on the actual value delivered and seek a long relationship with their clients resulting in measurable shareholder value enhancement. | Finance |
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
University of Liege
University of Liege Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















